We are live on
!
Find out more
FC
Fore Capital Portfolio holdings
AUM
$338M
Turnover
62.67%
1-Year Est. Return
10.07%
This Fund
S&P 500
This Quarter
Est. Return
+0.81%
1 Year Est. Return
+10.07%
3 Year Est. Return
+25.37%
5 Year Est. Return
+23.47%
10 Year Est. Return
–
AUM
$294M
AUM Growth
+$99.4M
(+51%)
Cap. Flow
-$48.6M
Cap. Flow
% of AUM
-16.51%
Top 10 Holdings %
Top 10 Hldgs %
77.87%
Holding
65
New
15
Increased
5
Reduced
5
Closed
20
Avg Time Held Equity + Options
0.7
years
Top 10 Avg Time Held Equity + Options
0.3
years
Top 20 Avg Time Held Equity + Options
0.4
years
Avg Time Held Equity only
0.9
years
Top 10 Avg Time Held Equity only
0.2
years
Top 20 Avg Time Held Equity only
0.7
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AstraZeneca
AZN
|
+$2.06M |
| 2 |
Sotera Health
SHC
|
+$1.32M |
| 3 |
iShares Silver Trust
SLV
|
+$1.08M |
| 4 |
Sanofi
SNY
|
+$989K |
| 5 |
Silicom
SILC
|
+$931K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
U.S. Equity Ex-Dividends Fund - Series 2027
XDIV
|
+$14.5M |
| 2 |
AT&T
T
|
+$1.89M |
| 3 |
Organon & Co
OGN
|
+$1.48M |
| 4 |
EQT Corp
EQT
|
+$1.02M |
| 5 |
Enterprise Products Partners
EPD
|
+$673K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 96.33% |
| 2 | Healthcare | 1.64% |
| 3 | Technology | 0.81% |
| 4 | Materials | 0.39% |
| 5 | Utilities | 0.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
26
Viatris
VTRS
$20.9B
| $135K | 0.05% |
+10,000
| New | +$134K |
2021 Q4
0 quarters
|
|
27
Matinas BioPharma
MTNB
$2.37M
| $10K | ﹤0.01% |
13
| – | – |
2018 Q1
15 quarters
|
|
28
Xtrackers Harvest CSI 300 China A-Shares ETF
ASHR
$1.34B
| – | – |
-10,000
| Closed | -$381K | – |
|
29
CALL
Optimum Communications Inc
OPTU
$366M
| – | – |
-135,000
| Closed | -$2.8M | – |
|
|
30
Optimum Communications Inc
OPTU
$366M
| – | – |
-30,000
| Closed | -$622K | – |
|
|
31
PUT
Optimum Communications Inc
OPTU
$366M
| – | – |
-100,000
| Closed | -$2.07M | – |
|
|
32
PUT
Enterprise Products Partners
EPD
$76.8B
| – | – |
-50,000
| Closed | -$1.08M | – |
|
|
33
EQT Corp
EQT
$32.8B
| – | – |
-50,000
| Closed | -$1.02M | – |
|
34
CALL
VanEck Gold Miners ETF
GDX
$26.1B
| – | – |
-150,000
| Closed | -$4.42M | – |
|
35
PUT
iShares Morningstar Value ETF
ILCV
$1.38B
| – | – |
-200,000
| Closed | -$17.5M | – |
|
36
CALL
Inovio Pharmaceuticals
INO
$108M
| – | – |
-8,333
| Closed | -$716K | – |
|
37
CALL
iQIYI
IQ
$948M
| – | – |
-100,000
| Closed | -$803K | – |
|
38
CALL
Merck
MRK
$358B
| – | – |
-150,000
| Closed | -$11.3M | – |
|
|
39
Organon & Co
OGN
$3.61B
| – | – |
-45,000
| Closed | -$1.48M | – |
|
40
PUT
Scorpio Tankers
STNG
$4.15B
| – | – |
-112,000
| Closed | -$2.08M | – |
|
|
41
CALL
AT&T
T
$161B
| – | – |
-198,600
| Closed | -$4.05M | – |
|
|
42
AT&T
T
$161B
| – | – |
-92,680
| Closed | -$1.89M | – |
|
|
43
PUT
AT&T
T
$161B
| – | – |
-92,680
| Closed | -$1.89M | – |
|
44
PUT
Vistra
VST
$51.7B
| – | – |
-50,000
| Closed | -$855K | – |
|
45
CALL
Verizon
VZ
$184B
| – | – |
-130,000
| Closed | -$7.02M | – |
|
|
AUD
46
DELISTED
Audacy, Inc.
AUD
| – | – |
-150,000
| Closed | -$552K | – |
|
|
47
DELISTED
U.S. Equity Ex-Dividends Fund - Series 2027
XDIV
| – | – |
-149,997
| Closed | -$14.5M | – |
|
Similar funds
EWA
ECAM
1CM
NIWA
HFS
CWM
BAM
JWM
Fore Capital's Q4 2021 Portfolio in Review
As of Q4 2021, Fore Capital held 65 positions worth $294M, up 51% from $195M the previous quarter. Its ten largest holdings account for 78% of the portfolio.
Fore Capital withdrew a net $48.6M in Q4 2021, closing 20 positions and reducing 5 holdings. Its most notable exit was U.S. Equity Ex-Dividends Fund - Series 2027, an estimated $14.5M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 96% of assets, up from 95% a quarter earlier, followed by Healthcare and Technology.
Against the trend, Fore Capital opened a new position in AstraZeneca worth $2.04M.
- Fore Capital's largest Q4 2021 buy was AstraZeneca: 17,500 shares worth $2.04M.
- Fore Capital added most to Silicom in Q4 2021, an estimated $931K increase.
- Fore Capital's biggest Q4 2021 reduction was Enterprise Products Partners, cutting an estimated $673K.
- Fore Capital fully exited U.S. Equity Ex-Dividends Fund - Series 2027 in Q4 2021, selling an estimated $14.5M.
- Fore Capital's ten largest holdings make up 78% of its $294M portfolio in Q4 2021.
- Fore Capital opened 15 new positions and closed 20 in Q4 2021.
- Fore Capital's portfolio value rose 51% quarter-over-quarter to $294M.
Based on Fore Capital's 13F filing for Q4 2021, filed 11 Feb 2022.